endometriosis
Conditions
Interventions
The subject patient is administered aglycone isoflavones at 30 mg / day for 3 months.
Sponsors
Kyoto Prefectural University of Medicine, Graduate School of Medical Science
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patients with chronic pelvic pain whose VAS 2.0 or higher menstrual cycle days are within 25 to 38 days.
Exclusion criteria
Exclusion criteria: (1) Patients who used patients who had taken nutritional supplements containing soy isoflavone within 3 months of receiving visits (2) Within 3 months of receiving visits, we used an analog formulation of GnRH, an endocrine formulation based on luteinizing hormone or follicle hormone, a low dose pill, a middle dose pill, a testosterone derivative and a Chinese medicine having indication for endometriosis patient (3) Patients who underwent surgical treatment for endometriosis by vaginal alcohol fixation, laparotomy, laparoscopy within 3 months of receiving visits (4) Patients who are suspected of being pregnant or pregnant at the time of visit (5) At the time of consultation, a patient who is a nursing woman (6) Patients judged inappropriate by the attending physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of visual analogue scale before and after administration of isoflavone. | — |
Countries
Japan
Contacts
Public ContactOsamu takaoka
Kyoto Prefectural University of Medicine, Graduate School of Medical Science Department of Obstetrics and Gynecology
Outcome results
None listed